2024

Educational materials on the risks of infusion reactions, medication errors associated with home infusions, and risks for pregnant women and women of reproductive potential during treatment with the medicinal product XENPOZYME (olipudase alfa)

Educational materials for healthcare professionals and patients on the risks of infusion reactions, errors during home infusions, and risks for pregnant women and women of reproductive potential during treatment with XENPOZYME (olipudase alfa). generated automatically

Communication materials on the risk of neurodevelopmental disorders in children born to men who used valproates (DEPAKINE®, DEPAKINE® ENTERIC 300, DEPAKINE CHRONO® 300 mg, DEPAKINE CHRONO® 500 mg)

Informational materials for healthcare professionals and patients on the risk of neurodevelopmental disorders in children born to men who used valproates. They contain recommendations for preventing such risks. generated automatically

Communication materials on the safe use of the medicinal product LENANGIO (lenalidomide)

Communication materials for patients regarding the potential risk of HIV seroconversion and development of resistance with the use of the medicinal product Apretude

Patient card with safety information to be aware of when using the medicinal product OBAJIO®

Patient reminder card on safety precautions to know before and during treatment with zoledronic acid (medicinal product VISTAZOL)

Training materials on the safe use of the medicinal product LENALIDOMIDE-VISTA

Patient reminder card on the use of the medicinal product Voriconazole

Educational materials on the safe use of the medicinal products MIKOFIT, MARELIM MARELIM

Communication materials on the safety of use of the medicinal product SIBINCVO “Patient Card”